TFCP
NVO

Twin Focus Capital Partners’s Novo Nordisk NVO Stock Holding History

Twin Focus Capital Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,518
Closed -$285K – 207
2023
Q2 		$285K Buy
3,518
+168
+5% +$13.7K 0.06% 170
2023
Q1 		$267K Buy
3,350
+356
+12% +$25.2K 0.05% 178
2022
Q4 		$203K Buy
+2,994
New +$176K 0.04% 210

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Twin Focus Capital Partners's NVO Position: Q3 2023 in Review

Twin Focus Capital Partners sold out of Novo Nordisk (NVO) in Q3 2023, closing a stake of 3,518 shares — an estimated $285K sold.

Twin Focus Capital Partners first reported a position in NVO in Q4 2022 and held it in 3 quarters. The position peaked at $285K in Q2 2023. 1,307 funds tracked by Wall St. Rank hold NVO as of Q3 2023.

  • Twin Focus Capital Partners reported no remaining Novo Nordisk position as of Q3 2023 after selling out during the quarter.
  • Twin Focus Capital Partners sold 3,518 Novo Nordisk shares in Q3 2023, an estimated $285K.
  • Twin Focus Capital Partners first reported a position in Novo Nordisk in Q4 2022 and held it in 3 quarters.
  • Twin Focus Capital Partners's Novo Nordisk position peaked at $285K in Q2 2023.
  • 1,307 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2023.

Based on Twin Focus Capital Partners's 13F filing for Q3 2023, filed 13 Nov 2023.